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Abstract
Protein aggregation is a major problem for biopharmaceuticals. While the control of aggregation is
critically important for the future of protein pharmaceuticals, mechanisms of aggregate assembly,
particularly the role that structure plays, are still poorly understood. Increasing evidence indicates
that partially folded intermediates critically influence the aggregation pathway. We have
previously reported the use of the basic leucine zipper (bZIP) domain of Activating Transcription
Factor 5 (ATF5) as a partially folded model system to investigate protein aggregation. This
domain contains three regions with differing structural propensity: a N-terminal polybasic region,
a central helical leucine zipper region, and a C-terminal extended valine zipper region.
Additionally, a centrally positioned cysteine residue readily forms an intermolecular disulfide
bond that reduces aggregation. Computational analysis of ATF5 predicts that the valine zipper
region facilitates self-association. Here we test this hypothesis using a truncated mutant lacking
the C-terminal valine zipper region. We compare the structure and aggregation of this mutant to
the wild-type (WT) form under both reducing and non-reducing conditions. Our data indicate that
removal of this region results in a loss of alpha-helical structure in the leucine zipper and a change
in the mechanism of self-association. The mutant form displays increased association at low
temperature but improved resistance to thermally induced aggregation.
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Introduction
Protein aggregation is a major concern of the biopharmaceutical industry.1 The aggregation
of protein products may not only lead to a decrease in drug potency, but aggregated species
can also display enhanced immunogenicity.2 Consequently, controlling the formation of
protein aggregates in a pharmaceutical formulation is of great importance. The difficulty in
preventing aggregation partially stems from our lack of understanding of the mechanism by
which aggregates form. In particular, the role that protein structure plays in this process is
poorly understood. Increasing evidence suggests that partially folded protein intermediates
critically influence the aggregation pathway; however, this relationship remains ill-defined.3
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Two general categories of protein aggregates have been reported in the literature: amyloid
fibrils and amorphous aggregates.4 Fibrillar aggregates have received much attention due to
their association with a growing number of serious disease states for which limited treatment
options exist.4c, 5 They are characterized by a cross-beta structure, in which the beta strands
align in a highly organized format along the long-axis of the fibril.4c, 5a, 6 Amorphous
aggregates are often associated with recombinant protein production and purification in
vitro; however increasing evidence indicates that a number of proteins can develop into both
fibrillar and amorphous aggregates in vitro.7 The nature of the aggregated species is highly
dependent upon protein sequence and solution conditions that control protein conformation.7
Amorphous aggregates are so named because unlike fibrillar aggregates, they do not display
long-range order.3h, 4a, 4d However, these aggregates do possess structure and, typically, an
increase in intermolecular beta-sheet content is observed compared to the native state.3h, 4a, 8
This is not true in all cases, and the development of alternative structures, including alpha
helix, has been reported in aggregates.3g, 9 It is currently unclear how the amino acid
sequence and higher order structure directs aggregate assembly and organization.
We have previously reported the production of the basic leucine zipper (bZIP) domain of
activating transcription factor 5 (ATF5), a notable protein target for treatment of
glioblastoma.10 Because of its propensity to aggregate in vitro, we have used ATF5 as a
model system to investigate protein aggregation.11 Our previous data indicate that disulfide
bond formation prevents the formation of large amorphous protein aggregates through
improved retention of alpha-helical structure.11 Computational analysis predicted that the C-
terminal region, which contains a series of three valine residues (V257, V264 and V271) in
lieu of the conserved leucine residues typically observed in these positions, most likely
facilitates aggregation.11 We suggested that disulfide bond formation minimized solution
exposure of this C-terminal region through improved structural retention, resulting in
diminished protein aggregation.11 The work presented here further characterizes the
contribution of this C-terminal region to the aggregation of ATF5.
A mutant form of the ATF5 protein that lacks the C-terminal region (residues 257–282) was
created using site-directed mutagenesis. This variant (V257STOP) was created via the
insertion of a stop codon immediately preceding the first valine residue (V257) in this
region. The structure of the purified mutant form of ATF5 was evaluated using circular
dichroism spectroscopy (CD), Fourier transform infrared (FTIR) spectroscopy and two-
dimensional nuclear magnetic resonance (NMR) spectroscopy. The results were compared
with that of the wild-type (WT) form of ATF5 to determine the effect of C-terminal
truncation on protein structure. The extent of thermal aggregation of both proteins was
monitored using static light scattering (SLS) analyses and dynamic light scattering (DLS)
analyses. Structural changes that occurred during the aggregation process were evaluated
using FTIR analysis. These data were collectively used to compare the formation and
growth of protein aggregates of both the WT and V257STOP forms of ATF5 and identify
correlations between protein structure and aggregate development. Our data indicate that
removal of the C-terminal region of ATF5 changes the structure of the protein and the
mechanism of thermally induced protein self-association.
Materials and Methods
Protein Expression and Purification
The cDNA of ATF5 was obtained through ATCC (MGC-842), and the bZIP domain was
PCR amplified and inserted into a Novagen (San Diego, CA) pET-42b vector as described
previously.10a The V257STOP truncated mutant was generated using site-directed
mutagenesis to insert a stop codon at the valine in position 257. Mutagenesis was performed
by GenScript USA (Piscataway, NJ). Plasmids were transformed into Novagen BL21(DE3)
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E. coli for expression. Cell growth, lysis and purification were performed using the
procedure described previously with the following modification.10a Unlike wild type, the
truncated mutant was present largely in the soluble fraction following cell lysis and
centrifugation. This fraction was heated at 60 °C for 1 hour to precipitate the majority of
cellular proteins. The mutant remained soluble under these conditions. To ensure that any
aggregates formed during this purification step were eliminated the protein was denatured
and subsequently subjected to the same refolding procedure as previously described for the
WT.10a Protein concentrations were determined using a standard Bradford assay. The purity
of ATF5 was determined using densitometry of Coomassie stained SDS-PAGE gels.10a This
method was also used to confirm intermolecular disulfide bond formation using non-
reducing conditions. Isotopic labeling for two-dimensional NMR was accomplished during
cellular expression with the use of 15N-ammonium chloride (>99% N-15; Isotec, St. Louis,
MO).
Circular Dichroism Spectroscopy
Circular dichroism (CD) spectra were acquired with an Applied Photophysics Chirascan
(Leatherhead, UK) equipped with a Peltier-type temperature controller and a four-position
sample holder. ATF5 WT and V257STOP samples were prepared at a final protein
concentration of 10 μM in 20 mM MES buffer at pH 6.0. Scans were performed at 10 °C in
a 0.1-cm path length cell from 260 to 190 nm. The selected bandwidth was 4 nm, the data
pitch was 1 nm and the sampling time was 0.5 sec. Samples were prepared and analyzed in
duplicate. Raw data were converted into units of molar ellipticity using the standard
formula, [θ] = θ*M*10/C*l, where [θ] is the molar ellipticity, θ is the ellipticy in mdeg, M
is the molecular weight in mg/mmol, C is the concentration in mg/mL and l is the path
length in cm. Multiplying by 10 facilitates the conversion from millimoles to decimoles,
resulting in the final units of deg*cm2*dmol−1. The resulting average and standard
deviations were plotted.
Fourier Transform Infrared Spectroscopy
Absorption spectra (256 scans) were collected at a 5 mg/mL concentration from 900 to 4000
cm−1 at a resolution of 4 cm−1 on a Bruker (Billerica, MA) Tensor 27 Fourier transform
infrared spectrophotometer instrument using a Harrick Scientific Products (Pleasentville,
NY) BioATR Cell II sample apparatus and a Thermo Scientific (Waltham, MA) Haake
DC30-K20 refrigerated circulator bath under constant nitrogen purge. The
spectrophotometer was equipped with a KBr beam splitter and a liquid-nitrogen-cooled
mercury cadmium telluride (MCT) detector. Reference spectra consisting of 20 mM MES
buffer pH 6.0 with or without 10 mM dithiothreitol (DTT) were collected prior to each
sample solution and subtracted as background. Resultant spectra were first processed using
OPUS 6.5 software (Bruker Optics). A correction was performed to minimize absorption
interference from atmospheric water and carbon dioxide. The minimum and maximum
values within the amide I region (1600–1700 cm−1) were normalized. Data were then further
processed using GRAMS/AI 8.0 spectroscopy software (Thermo Fisher Scientific). A
baseline correction was performed, and the data were smoothed using a five-point Savitsky-
Golay function. Fourier self-deconvolution was performed and the data were fitted by
inserting individual Gausssian bands to match the second derivative peak position.
Secondary structure assignments were made based upon reference spectra reported in the
literature.12
The temperature was increased from 10 °C to 90 °C to facilitate thermal analysis of stability.
Scans (256) were collected every 2.5 °C at a ramping rate of 2.5 °C per minute. A reference
melt consisting of 20 mM MES buffer pH 6.0 with or without 10 mM dithiothreitol (DTT)
was collected immediately prior to sample analysis and subtracted as background. The
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resultant spectra were processed using OPUS 6.5 software. A correction was performed to
minimize absorption interference from atmospheric water and carbon dioxide. The minimum
and maximum values within the amide I region (1600–1700 cm−1) were normalized. The
absorbance spectra in the Amide I region were plotted as a function of temperature.
Nuclear Magnetic Resonance Spectroscopy
Two-dimensional 1H-15N heteronuclear single quantum coherence (HSQC) spectra were
recorded at 25 °C using a Bruker AVANCE 800 MHz spectrometer equipped with a triple-
resonance CRYO-probe with pulse field gradients. Samples were prepared at a
concentration of 1 mM in 20 mM MES buffer pH 6.0, containing 5% D2O. Water
suppression was accomplished using flip-back pulses. Data were acquired in 8 scans with
1024 points in 1H and 128* increments in 15N. 1H chemical shifts were referenced with
respect to an external DSS standard in D2O.13 Indirect referencing relative to 1H was
determined for 15N, assuming a ratio of 15N/1H = 0.101329118. Data were processed using
NMRPipe and Sparky software.14
Static Light Scattering
Static light scattering (SLS) data were acquired with a Photon Technology International
(PTI) spectrofluorometer (Lawrenceville, NJ) equipped with a Peltier-type temperature
controller and a four-position sample holder. Samples were prepared at a final protein
concentration of 100 μM in 20 mM MES buffer at pH 6.0 in the presence or absence of 10
mM DTT. 10 μM and 1 μM samples were analyzed to examine the effect of protein
concentration on aggregation. The intensity of scattered light was measured as a function of
temperature and detected at an angle of 90° to the light source by a photomultiplier tube. An
arc lamp white light source was used in all cases. The excitation wavelength was set at 350
nm. The emission wavelength range was set from 300 nm to 400 nm. Spectra were obtained
following a 5-min equilibration period at each temperature. Data were collected every 2.5 °C
between the temperature range of 4 to 81.5 °C. The background was subtracted from each
data point based on a blank containing the corresponding buffer solution. Two samples were
prepared and analyzed for each set of solution conditions. The resulting average and
standard deviations were plotted.
Dynamic Light Scattering
The average hydrodynamic radius was monitored as a function of temperature using a Wyatt
Technology Corporation (Santa Barbara, CA) DynaPro Plate Reader Plus instrument. ATF5
WT and V257STOP samples were prepared in 20 mM MES buffer pH 6.0 at a final
concentration of 100 μM in the presence or absence of 10 mM DTT. Samples containing the
isolated V257STOP aggregate or monomer species were prepared at a 40 μM concentration
in phosphate buffered saline (PBS) at pH 7.4. All samples were filtered before analysis
using a 0.2 μm Anotop 10 Whatman (Piscataway, NJ) 10 mm inorganic syringe filter. A
384-well Corning (Corning, NY) polystyrene plate was used for these experiments. Data
were obtained in three consecutive acquisition periods, each 15 seconds in length, and
averaged. Acquisitions were obtained every 2.5 °C over a temperature range of 10 °C to
67.5 °C with a ramping rate of 1 °C/min. A constant nitrogen purge at 60 cc/min and 60 psi
was performed to prevent condensation. Average hydrodynamic radii and polydispersity
indices were calculated using cumulant analysis.15 Two samples were prepared and
analyzed for each set of solution conditions. The resulting average and standard deviations
were plotted. Particle distribution was evaluated using a nonnegative least squares
regularization method of analysis.16 A representative data set for each form of ATF5 was
plotted.
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Fluorescence data were acquired with a Photon Technology International (PTI)
spectrofluorometer (Lawrenceville, NJ) equipped with a Peltier-type temperature controller
and a four-position sample holder. Samples were prepared at a final protein concentration of
100 μM in 20 mM MES buffer at pH 6.0 in the presence or absence of 10 mM DTT.
Thioflavin T dye (Sigma-Aldrich; St. Loius, MO) was added at a final concentration of 10
μM. Fluorescence intensity was measured as a function of temperature and detected at an
angle of 90° to the light source by a photomultiplier tube. An arc lamp white light source
was used in all cases. The excitation wavelength was set at 450 nm. The emission
wavelength range was set from 400 nm to 500 nm. Spectra were obtained following a 5-min
equilibration period at each temperature. Data were collected every 2.5 °C between the
temperature range of 10 to 80 °C. The background was subtracted from each data point
based on a blank containing the corresponding buffer solution. Two samples were prepared
and analyzed for each set of solution conditions. The resulting average and standard
deviations were plotted.
Results
Effects of C-terminal Truncation on ATF5 Structure
Circular dichroism (CD) spectroscopy was performed to evaluate differences in secondary
structure between the wild type (WT) and the truncated mutant (V257STOP) forms of
ATF5. The mutant protein displays a CD absorption spectrum that is distinct from the WT
form (Figure 1). The WT possesses a double-minima absorption pattern with negative peaks
at 222 nm and 208 nm. This pattern is indicative of α-helical protein structure.17 Given that
the extended C-terminal portion of the protein was removed to make the V257STOP protein,
one would expect that the remaining leucine zipper region would retain helicity. The
V257STOP mutant displays a single absorption minimum at 209 nm and a broad shoulder
between 260 nm and 230 nm, which is not consistent with alpha-helical structure and
indicates a substantial structural change has occurred in the absence of the valine zipper
region. Negative absorption at 209 nm has been observed for proteins possessing β-
structure.18 Additionally, it has been reported that certain types of β-bend can give negative
absorption at 208 nm.19 The absorption observed between 260 nm and 230 nm could be
attributed to β-turn structure, which has been demonstrated to display CD signal in this
region.20
Further experimental analysis of secondary structure was performed using Fourier transform
infrared spectroscopy (FTIR) to better understand these structural differences.
Deconvolution of FTIR absorption in the Amide I region for the WT and V257STOP forms
of ATF5 also indicates that the two proteins possess distinctly different secondary structure
(Figures 2 and 3). The absorption peaks observed here are broader than those typically
observed for a well-structured system.21 The data for both forms of ATF5 are suggestive of
a mixed state or partially folded system. The WT form displays absorption peaks at 1621
cm−1, 1650 cm−1, 1676 cm−1 and 1688 cm−1. The absorption band at 1621 cm−1
corresponds to intermolecular β-sheet structure.12a, 22 The dominant absorption peak
observed at 1650 cm−1 corresponds to α-helical structure.12a, 22 The absorption peak
observed at 1676 cm−1 could represent β-sheet or β-turn structure.12a, 22 Strong β-sheet
absorption at low wavenumbers in the Amide I region (1620 cm−1 to 1639 cm−1) is often
accompanied by weaker absorption at higher wavenumbers (1670 cm−1 to 1680 cm−1).21c, 23
It is likely, based upon the absorption observed at 1621 cm−1, that the peak at 1676 cm−1
primarily represents β-sheet structure. Lastly, the absorption peak at 1688 cm−1 is reflective
of β-turn structure.12a, 22
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The V257STOP mutant form of ATF5 displays broad absorption peaks at 1644 cm−1 and
1682 cm−1. While the fitting procedure resulted in the placement of two broad peaks for the
mutant form, the second derivative data suggest the presence of two states, one of which
may be α-helical (1650 cm−1) and the other unordered structure (1641 cm−1).12a, 22, 24 The
broad absorption peak at 1682 cm−1 could represent β-sheet and/or β-turn structure.12a, 22
The absorption band observed at 1601 cm−1 likely corresponds to side chain vibrations and
is not predictive of secondary structure.25
Additional studies were performed using two-dimensional NMR to compare chemical shift
signal dispersion for the two forms of ATF5 (Figure 4). The 1H-15N heteronuclear single
quantum coherence (HSQC) experiment used here gives an indication of overall protein fold
and structure based upon signal dispersion. This experiment can also provide general insight
into protein dynamics, which are reflected in and often dictate peak shape and intensity.
Both forms of ATF5 display NH signals largely between 8.0 and 8.5 ppm on the 1H-axis
(Figure 5). Much of the signal observed between 6.5 ppm and 7.5 ppm arises from NH2
groups in the Asn and Gln side chains, which typically have chemical shifts distinct from
those of the NH groups in the amide backbone. While some overlap in backbone signal is
observed between the two forms of ATF5, their chemical shifts are largely distinct, which
reaffirms the substantial differences in their overall structure and/or conformational
dynamics. A qualitative comparison of peak shape between the two spectra suggests that
both forms of ATF5 possess well-defined structural regions as well as more
conformationally labile regions. This is illustrated by the presence of both sharp, circular
cross-peaks that correspond to well-defined structure and broad, misshapen cross-peaks,
which are indicative of conformational exchange. The NMR signal intensity is proportional
to the concentration of protein and approximately reflects the amount of protein that is
present in the monomeric/dimeric state. Large molecular weight species are not observed in
the standard HSQC experiment, in this case self-associated species composed of more than
approximately 8–10 protomers. At the same molar concentration the signal to noise ratio
observed in these experiments was 1.8-fold greater for the WT form than for the truncated
mutant. This suggests that roughly 45% of the mutant protein’s NMR signal was not
observed due to protein aggregation. No visible precipitation was observed in the NMR
sample tube, which indicates that the aggregate species must be soluble in nature.
Analysis of Change in Structure Observed During ATF5 Aggregation
In order to investigate the structural changes that accompany aggregate growth and
development, FTIR analysis was employed. This technique permits the analysis of sample
both in solution and in the solid state, thereby allowing us to monitor structural changes that
occur as the protein precipitates. In these experiments, FTIR absorption was monitored for
both forms of ATF5, each under reducing and non-reducing conditions, as a function of
temperature (Figure 5). The WT form begins to change structure between 10 °C and 25 °C.
This transition is characterized by a loss in α-helical structure at 1650 cm−1 and an increase
in β-sheet structure at 1620 cm−1 (See SI, Figures S1 and S2). Increased absorption at ~1620
cm−1 is typically observed during protein aggregation and is indicative of intermolecular β-
sheet structure.21a, 21c, 23 In the presence of DTT, two isobestic points are observed for the
WT melt (~1630 cm−1 and 1670 cm−1). This suggests that the loss of helical structure is
directly linked to a gain in structure at lower and higher wavenumber. In contrast, a more
complex structural transition is observed for the WT form in the absence of DTT. In this
case, an initial loss of signal is observed between 10 °C and 25 °C at lower wavenumber,
followed by a subsequent increase in β-sheet signal at 1620 cm−1.
Interestingly, the V257STOP mutant form of ATF5 does not change structure until the
temperature rises above 40 °C. A decrease in unordered absorption at 1644 cm−1 and an
increase in intermolecular β-sheet absorption at 1620 cm−1 are then observed. A loss in
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absorption at higher wavenumber (between 1670 cm−1 to 1700 cm−1) is also observed as a
function of temperature. This suggests a reduction in β-sheet or β-turn structure. This loss
continues until the temperature exceeds 70 °C, where a slight increase in absorption in this
region is then observed. The structural transitions observed for the V257STOP mutant are
largely unaffected by DTT addition.
Effects of C-terminal Truncation on ATF5 Aggregation
Static light scattering (SLS) analysis was performed to compare the growth of thermally
induced protein aggregates between the WT and V257STOP forms of ATF5. In these
experiments the average intensity of scattered light was measured in counts per second as a
function of temperature under both reducing and non-reducing conditions (Figure 6). The
onset of aggregation occurs at a much lower temperature for the WT form of ATF5 than for
the V257STOP mutant. In the presence of DTT, WT aggregation is characterized by a sharp
increase in scattering intensity between 25 °C and 30 °C. The scattering intensity eventually
levels off and starts to decline at high temperature (between 70°C and 80 °C) due to the
settling of large particles out of solution. This was confirmed by visual inspection of
samples following the melt. In the absence of DTT, the WT onset of aggregation is shifted
to higher temperature. An increase in scattering intensity is not observed until almost 40 °C.
Additionally, particulate growth appears to be more gradual under these conditions.
Aggregation onset for the V257STOP mutant form of ATF5 is not observed until the
temperature exceeds 50 °C. Aggregation of this species is depicted by a gradual increase in
scattering intensity observed between 60 °C and 70 °C, followed by a sharper increase in
scattering intensity between 70 °C and 80 °C. Unlike WT, the aggregation of this form of
ATF5 is unaffected by the addition of DTT. Additional SLS studies were performed at lower
concentration (10 and 1 μM; data not shown). Notably, the WT form aggregated less readily
at these lower concentrations under both reducing and non-reducing solutions conditions,
whereas the particle size and onset temperature of V257STOP mutant remained unaffected
by altering the concentration. Further investigation was performed using dynamic light
scattering (DLS) analysis to evaluate particle size distribution as a function of temperature
using the 100-μM samples.
DLS uses autocorrelation analysis to measure the time-dependent fluctuations in light
scattering intensity. The autocorrelation function reflects particle diffusion in solution,
which is directly related to particle size. In these experiments the autocorrelation function
was acquired at increasing temperatures for the two forms of ATF5 under both reducing and
non-reducing solution conditions. Cumulant analysis provided an average hydrodynamic
radius (RH) value and polydispersity index for the particles in solution (Figure 7).15
The WT form of ATF5 displays an average RH of 10 nm at 10 °C under both reducing and
non-reducing solution conditions. This average value is unchanged at low temperatures but
begins to gradually increase in size between 25 °C and 30 °C. While this trend is the same
for the WT protein under both reducing and non-reducing conditions, the average value
becomes slightly larger for the reduced sample as a function of temperature. In contrast, the
V257STOP mutant form of ATF5 maintains an average RH of approximately 22 nm at
nearly all temperatures measured. A slight increase in average RH occurs for the V257STOP
form as the temperature exceeds 60 °C. (Analysis above 65 °C was not performed, because
the polystyrene plates used in these experiments cannot be used above this temperature.)
Again, there is no distinction between data collected under reducing and non-reducing
solution conditions for the V257STOP mutant for ATF5. When these experiments were
performed at 10 and 1-μM protein concentrations, the WT again displayed concentration
dependence, whereas the V257STOP mutant remained unaffected.
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While this data provides useful information about trends associated with increasing
temperature, the cumulant analysis provides an average RH value. The polydispersity index
reported with the average value provides an estimation of distribution about the mean. The
polydispersity values reported for both the WT and V257STOP systems suggest multimodal
sample populations (Figure 8). Additionally, the average values reported here are much
larger than what would be expected for ATF5 monomer or dimer. For example an IgG
mononclonal antibody with an estimated molecular weight of 150 kDa typically displays an
average hydrodynamic radius of approximately 12 nm. 26 This suggests that self-associated
protein species are present in both the WT and V257STOP samples. Solution polydispersity
decreases for both forms of ATF5 as particle size increases (Figure 8). This could be related
to the development of micron-size protein aggregates that exceed the 1 μm size limit of DLS
detection. As protein precipitates from solution, the polydispersity of the remaining soluble
species may be lowered.
Regularization analysis is an alternative method for analyzing DLS data that makes no
assumptions about sample homogeneity and permits characterization of multimodal sample
populations.16 This analysis was performed on the dynamic light scattering data collected
for both forms of ATF5 between 10 °C and 65 °C. The data is plotted as a distribution
illustrating the relative intensity of light scattered as a function of particle size in solution
(Figure 9). The data for both forms of ATF5 indicate heterogeneous, multimodal sample
populations. The WT sample contains two sample populations, a smaller species ranging
from approximately 2 nm to 4 nm in radii that likely represents monomeric or dimeric
protein and a larger population that ranges from 8 nm to 35 nm in size and consists of
aggregated protein species. The V257STOP sample also contains two sample populations. A
smaller species ranging again from approximately 2 nm to 4 nm in radii that reflects
monomeric or dimeric protein and a larger population ranging from 10 nm to 70 nm in size
that is consistent with aggregated species.
The range in size observed for protein monomer/dimer by DLS is consistent with the NMR
data, which indicates a partially folded and highly flexible monomer/dimer. DLS analysis of
the aggregated species indicates the existence of particles of varying sizes. Interestingly, the
V257STOP mutant form consistently displays a much broader size range of aggregated
protein than the WT form. Moreover, this distribution remains relatively constant across the
temperatures and concentrations measured. The lack of concentration dependence of
V257STOP as determined by SLS further indicates the 22-nm, soluble aggregates are stable.
This result coupled with the consistently elevated thermal transition temperature of the
mutant implies the protein molecules are associated in an organized structure. This is in
contrast to the WT, where the aggregated population steadily increases in size as a function
of temperature. This suggests that aggregation of the WT form occurs through growth to
increase the size of soluble protein aggregates to 10–35 nm.
To further probe the structure of the soluble aggregates, Thioflavin T fluorescence was
measured in the presence of both forms of ATF5 as a function of temperature (See SI,
Figure S3). Thioflavin T is a fluorescent dye commonly used for the detection of cross-beta
structure typically found in amyloid fibrils.27 Soluble aggregates of the truncated mutant
form of ATF5 were able to induce Thioflavin T fluorescence, whereas those composed of
the WT protein did not induce fluorescence. The emission intensity at 480 nm for the mutant
was 710,813 counts/second at 10 °C and the emission intensity for the WT at the same
temperature was 875 counts/second. Despite the presence of aggregates in both samples a
1000-fold increase in emission intensity was observed for V257STOP, indicating the
structures of the aggregates differ. At lower temperatures aggregates of the truncated variant
exhibit amyloid-like behavior in this assay, suggesting the helical leucine zipper region in
ATF5 adopts an alternative conformation to form these assemblies. In the WT protein, no
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fluorescence is detected, suggesting this region is protected from adopting the same
intermolecular structure as V257STOP by the adjacent valine zipper.
Discussion
In this report we compare the structure and aggregation of the wild-type (WT) form of ATF5
with a truncated mutant form that lacks the valine zipper region (V257STOP). The truncated
ATF5 displays a distinctly different structure than the WT form. Removal of the valine
zipper region results in a loss of α-helical structure. This is interesting because the leucine
zipper region of ATF5 is the region with the highest propensity to adopt α-helical structure,
whereas the valine zipper region is predicted to be disordered but have beta propensity.11
Based on this information, one would expect that removal of the valine zipper region would
result in an increased overall helical structure for the mutant, but the opposite effect is
observed. This indicates that the valine zipper region is important for maintaining the α-
helical structure of the adjacent helical region. If as predicted, the central leucine zipper
region is the most structured region of ATF5, then the valine zipper region must help
stabilize this helical structure. It is not clear whether structural stabilization is accomplished
through backbone or side-chain interactions or both.
The dynamic light scattering data indicate that both forms of ATF5 tend to self-associate at
low temperature (10 °C). The conformation of the monomer/dimer appears to be highly
dynamic by NMR analysis, but it is not clear to what extent exchange occurs between these
two species and the soluble aggregate at lower temperatures. Based on the NMR data
acquired using low millimolar concentrations of protein, a large percentage of these samples
must be present in their low molecular weight monomeric/dimeric form in order to be
observed on the NMR timescale.28 The structural data collected using CD and FTIR reflect
the structure of both free and self-associated protein species. Stable beta structure would
result in NH chemical shifts appearing further downfield, above 8.5 ppm, and no such signal
is observed in the NMR spectra. As such, it is likely that the helical signal observed for the
WT form of ATF5 is largely reflective of the base protomer structure and the intermolecular
β-structure observed reflects the presence of self-associated protein species.
The structural data collected on the mutant form of ATF5 indicate that the protein possesses
β-sheet and β-turn structure. However, the data also suggest that the system contains non-
standard structural features. Again, because ATF5 self-association occurs at low
temperature, the CD and FTIR data may reflect signal from both monomeric or dimeric
species and larger soluble aggregates. The complexity of this system precludes high-
resolution delineation of the structure of the V257STOP mutant.
To further probe the nature of the soluble aggregates, the samples were assayed for binding
to Thioflavin T. These data indicate that the initial aggregated or self-associated state of the
V257STOP mutant possesses a structure or conformation that is able to bind and induce
Thioflavin T fluorescence. Given that Thioflavin T fluorescence is typically observed in the
presence of fibrillar or amyloid aggregates, this suggests that the initial aggregated state of
the mutant protein possesses structural features that are similar to the cross-beta structure
present in amyloid fibrils.27 The fact that the WT form of ATF5 does not induce Thioflavin
T fluorescence further indicates a structural difference exists between the soluble aggregated
forms of the two proteins.
Despite a difference in the structure of the soluble aggregates, the FTIR data indicate that
the final aggregated states of the two forms of ATF5 are structurally similar. The increased
FTIR absorption signal at 1620 cm−1 is reflective of intermolecular β-structure and has been
observed for numerous aggregated protein species.21a, 21c, 23, 25 This suggests that while the
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pathway or mechanism leading to the formation of the final state may differ between
proteins, the structure of the final state is sequence independent.21a, 21c, 23, 25
It appears that the WT form of ATF5 protein possesses a conformation that readily permits
intermolecular β-sheet addition or elongation. Our initial hypothesis was that solution
exposure of the valine zipper region facilitated protein self-association through the initiation
of intermolecular β-structure. Therefore, under reducing conditions, where the valine zipper
region is more exposed, protein aggregation occurs more readily. Our data show that upon
removal of the valine zipper region, the bZIP domain still self-associates, but these soluble,
structured aggregates remain thermally stable and resist further aggregate growth up to high
temperature. This data suggests the mutant protein forms a structured, stable aggregate at
low temperature that involves the portion of the protein that is helical in the native state.
Moreover, the data suggest the adjacent sequence, although lacking in definable regular
secondary structure, supports retention of helical structure in this region of the native
protein, preventing formation of stable aggregates at low temperature. In addition, no
difference in aggregation is observed between the reduced and non-reduced forms of the
ATF5 mutant. Removal of the valine zipper region changes the conformation of the alpha-
helical region such that intermolecular disulfide bond formation is no longer a determining
factor in aggregate formation, structure or thermal stability.
Conclusions
We have shown that removal of the valine zipper region that lacks definable secondary
structure from ATF5 affects the structure of the adjacent, primarily α-helical leucine zipper
region, leading to a more disordered state. While both the WT and mutant forms of ATF5
readily self-associate, the soluble associated species differ in size and structure. The
differences between these two forms of ATF5 are also reflected in their thermal stability. A
much higher temperature is required to induce rapid aggregate growth for the mutant form
than for the WT. Additionally, aggregate growth for the V257STOP mutant is unaffected by
the presence of DTT. This study illustrates the critical relationship between protein structure
and aggregate assembly. Furthermore, this work lays the foundation for future high-
resolution studies that can be performed on these systems using multi-dimensional NMR.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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CD absorption spectra of the WT (red) and the V256STOP mutant (blue) forms of ATF5 in
20 mM MES pH 6.0 at 4 °C.
Ciaccio et al. Page 14











Second derivative of FTIR spectra for the WT (red) and V257STOP mutant (blue) forms of
ATF5 at 10 °C.
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Deconvolution of the FTIR absorption spectra for the WT (A) and V257STOP mutant (B)
forms of ATF5 at 10 °C. Absorption in the Amide I (1600–1700 cm−1) and Amide II (1500–
1600 cm−1) regions is plotted. The black outline denotes the parent absorption spectrum.
The pink overlay indicates the fitted spectrum. Individual absorption peaks in the Amide I
region are color-coded according the structure they represent (blue = extended structure; red
= alpha helix/unordered; green = extended structure/beta turn; purple = beta turn).
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2D 1H-15N HSQC spectrum of 1 mM 15N-labeled ATF5 WT (red peaks) and V257STOP
mutant (blue peaks) in 20 mM MES buffer, pH 6.0. Peaks corresponding to NH2 side chains
rather than NH backbone groups are boxed.
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FTIR absorption in the Amide I region is shown for the WT and V257STOP forms both
with and without 10 mM DTT at varying temperature. Panels A and B show data collected
on the WT form in the absence (A) and presence (B) of DTT. Panels C and D show data
collected on the V257STOP mutant form in the absence (C) and presence (D) of DTT. The
data shown was collected at 10 °C (red), 25°C (blue), 40 °C (green), 55 °C (purple), 70 °C
(light blue) and 90 °C (pink).
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SLS analysis of the 100 μM WT and V257STOP truncated forms of ATF5 in both the
absence and presence of 10 mM DTT. The intensity of scattered light is plotted as a function
of temperature. Data for the WT form in the absence and presence of DTT is illustrated in
red and purple, respectively. Data for the V257STOP mutant in the absence and presence
DTT is illustrated in blue and green, respectively.
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DLS analysis of the WT and V257STOP truncated forms of ATF5 in both the absence and
presence of 10 mM DTT. The average hydrodynamic radii are plotted as a function of
temperature. Data for the WT form in the absence and presence of DTT is illustrated in red
and purple, respectively. Data for the V257STOP mutant in the absence and presence DTT
is illustrated in blue and green, respectively.
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DLS analysis of the WT and V257STOP truncated forms of ATF5 in both the absence and
presence of 10 mM DTT. The polydispersity index is plotted as a function of temperature.
Data for the WT form in the absence and presence of DTT is illustrated in red and purple,
respectively. Data for the V257STOP mutant in the absence and presence DTT is illustrated
in blue and green, respectively.
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DLS distribution data for the (A) WT and (B) V257STOP truncated form of ATF5. The
percent intensity of scattered light is displayed as a function of hydrodynamic radius.
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